RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+10.81%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$4.15B
AUM Growth
+$4.15B
(+17%)
Cap. Flow
+$521M
Cap. Flow
% of AUM
12.54%
Top 10 Holdings %
Top 10 Hldgs %
45.29%
Holding
99
New
22
Increased
37
Reduced
6
Closed
9
Top Buys
| 1 |
Immunovant
IMVT
|
$63.1M |
| 2 |
Illumina
ILMN
|
$54.1M |
| 3 |
Guardant Health
GH
|
$52.5M |
| 4 |
Athira Pharma
ATHA
|
$45.4M |
| 5 |
Cytokinetics
CYTK
|
$40.7M |
Top Sells
| 1 |
Wave Life Sciences
WVE
|
$24.9M |
| 2 |
Q32 Bio
QTTB
|
$19.6M |
| 3 |
STAAR Surgical
STAA
|
$19M |
| 4 |
NeoGenomics
NEO
|
$13.8M |
| 5 |
Repare Therapeutics
RPTX
|
$6.98M |
Sector Composition
| 1 | Healthcare | 92.6% |
| 2 | Materials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Korro Bio
KRRO
$245M
| $47.3M | 1.14% |
2,461,486
+300,000
| +14% | +$5.76M |
|
27
Celldex Therapeutics
CLDX
$1.57B
| $46.3M | 1.11% |
3,120,137
+510,137
| +20% | +$7.57M |
|
|
28
Athira Pharma
ATHA
$15.5M
| $45.4M | 1.09% |
+2,668,913
| New | +$45.4M |
|
29
Establishment Labs
ESTA
$1.11B
| $43M | 1.03% |
2,319,138
| – | – |
|
|
NSTG
30
DELISTED
NanoString Technologies, Inc.
NSTG
| $42.3M | 1.02% |
947,134
| – | – |
|
|
31
Cytokinetics
CYTK
$5.98B
| $40.7M | 0.98% |
+2,000,000
| New | +$40.7M |
|
|
OYST
32
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $40.6M | 0.98% |
1,923,893
+14,533
| +0.8% | +$307K |
|
33
Castle Biosciences
CSTL
$673M
| $38.3M | 0.92% |
743,642
-59,868
| -7% | -$3.08M |
|
|
ISEE
34
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $37.6M | 0.9% |
6,663,439
+66,903
| +1% | +$377K |
|
|
DMTK
35
DELISTED
DermTech, Inc. Common Stock
DMTK
| $34.5M | 0.83% |
2,887,215
+31,450
| +1% | +$376K |
|
36
MacroGenics
MGNX
$121M
| $31.6M | 0.76% |
1,255,299
+9,483
| +0.8% | +$239K |
|
37
Milestone Pharmaceuticals
MIST
$151M
| $31.6M | 0.76% |
4,315,102
| – | – |
|
|
TRIL
38
DELISTED
Trillium Therapeutics Inc.
TRIL
| $30.7M | 0.74% |
+2,160,800
| New | +$30.7M |
|
39
Incyte
INCY
$17B
| $30M | 0.72% |
+334,144
| New | +$30M |
|
|
AVDL
40
Avadel Pharmaceuticals
AVDL
$1.42B
| $27M | 0.65% |
5,366,705
+60,135
| +1% | +$303K |
|
|
41
Q32 Bio
QTTB
$20.9M
| $26.9M | 0.65% |
2,517,906
-1,834,284
| -42% | -$19.6M |
|
42
OraSure Technologies
OSUR
$230M
| $25.3M | 0.61% |
2,075,082
+534,110
| +35% | +$6.5M |
|
43
ProQR Therapeutics
PRQR
$256M
| $23.8M | 0.57% |
4,973,174
+70,389
| +1% | +$337K |
|
|
VXRT
44
DELISTED
Vaxart
VXRT
| $23.4M | 0.56% |
+3,517,345
| New | +$23.4M |
|
|
CELL
45
DELISTED
PhenomeX Inc. Common Stock
CELL
| $22.9M | 0.55% |
+300,338
| New | +$22.9M |
|
46
TELA Bio
TELA
$65.4M
| $22.8M | 0.55% |
1,378,776
+14,418
| +1% | +$238K |
|
47
Johnson & Johnson
JNJ
$429B
| $22.3M | 0.54% |
149,761
+22,903
| +18% | +$3.41M |
|
|
ITOS
48
DELISTED
iTeos Therapeutics
ITOS
| $20.9M | 0.5% |
+902,855
| New | +$20.9M |
|
|
ADAP
49
Adaptimmune Therapeutics
ADAP
$13.9M
| $20.9M | 0.5% |
2,617,626
+17,626
| +0.7% | +$141K |
|
50
Outset Medical
OM
$245M
| $20.3M | 0.49% |
+405,000
| New | +$20.3M |
|